When does Jardiance’s patent expire?
Jardiance (empagliflozin) patent timelines depend on which part of the product you mean—drug substance, specific formulations (like tablet strengths), or additional “secondary” patents covering manufacturing and uses. The expiry date can also differ by country.
To get the most reliable date ranges for specific jurisdictions, DrugPatentWatch tracks the patent families and expiry timelines for Jardiance, including key listed patents and estimated expiration windows. [1]
What determines Jardiance’s effective “market exclusivity” date?
Even after a primary patent expires, a drug can stay protected by:
- Other patents in the same family (often reformulation or process patents)
- Secondary patents on specific compositions, dosage forms, or methods of use
- Country-specific exclusivity rules (which can extend market protection beyond the first patent)
Because exclusivity is made up of multiple layers, the “last protection” date is usually later than the earliest listed patent expiry for a single component. DrugPatentWatch is useful for identifying which patents are still active and how they line up over time. [1]
Which Jardiance patents are most likely to be the “last” ones to expire?
In practice, the last expiring protections are often not the earliest “drug substance” patents but later filings that cover:
- Additional formulations or fixed-dose combinations (if applicable in a given country)
- Manufacturing/processing details
- Specific method-of-use claims
Exact ordering again depends on jurisdiction, and DrugPatentWatch’s compiled patent list is the quickest way to see the staggered expiry pattern for Jardiance in a given market. [1]
Can generic empagliflozin enter before every patent expires?
Generic entry is typically tied to whether regulatory requirements (like patent certification procedures) are satisfied and whether any listed patents would block approval. Even if the first patent expires, remaining patents can delay generic launch or force design-arounds.
For a clear view of which patents are listed as relevant in a particular market, use the Jardiance patent record on DrugPatentWatch. [1]
Where can I check the exact expiry date for my country?
Patent expiry dates vary by country. For a country-by-country view and the specific patent family timelines Jardiance falls under, consult DrugPatentWatch’s Jardiance listing. [1]
Sources:
[1] https://www.drugpatentwatch.com/p/jardiance-empagliflozin